| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |